A1M Pharma has signed an agreement with Research Toxicology Centre, a leading European contract research organization with over 40 years of industry experience, as CRO partner for the company's preclinical toxicology studies. The practical preparations for the studies have now been initiated, fully in accordance with the company's development plan. In order to secure the best possible partner for the company's toxicology studies within treatment of preeclampsia, A1M Pharma evaluated a number of European contract research organizations (CROs). The company decided on the Italian Research Toxicology Centre (RTC) with over 40 years of industry experience and specialist knowledge in the type of studies A1M Pharma is preparing to perform. A1M Pharma and RTC have signed an agreement for these studies and initiated the practical preparations, such as the transfer process as well as establishing and validating bioanalytical methods.